Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials

BACKGROUND: A model was built that characterized effects of individual factors on five-year prostate cancer (PCa) risk in the Prostate, Lung, Colon, and Ovarian Cancer Screening Trial (PLCO) and the Selenium and Vitamin E Cancer Prevention Trial (SELECT). This model was validated in a third San Anto...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelfond, Jonathan A., Hernandez, Brian, Goros, Martin, Ibrahim, Joseph G., Chen, Ming-Hui, Sun, Wei, Leach, Robin J., Kattan, Michael W., Thompson, Ian M., Ankerst, Donna Pauler, Liss, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966358/
https://www.ncbi.nlm.nih.gov/pubmed/35351104
http://dx.doi.org/10.1186/s12894-022-00986-w